New drug shows promise for teen eczema sufferers in major trial
NCT ID NCT06277765
Summary
This study tested an investigational injectable drug called CM310 for teenagers with moderate-to-severe eczema. The main goal was to see if the drug could significantly clear skin and reduce itching compared to a placebo. It was a large, late-stage trial involving 180 participants across multiple centers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.